[Company Introduction]:
Novo Nordisk A/S is a leading entity in the Pharmaceuticals sector. Incorporated and publicly traded since 1974-05-17, the company has established its reputation as one of the key players in the market. As of today, Novo Nordisk A/S has a market capitalization of 3916439.99 in DKK, with 3338.43 shares outstanding.
Novo Nordisk A/S operates primarily in the DK, trading under the ticker NOVO B.CO on the OMX NORDIC EXCHANGE COPENHAGEN A/S. As a dominant force in the Pharmaceuticals space, the company continues to innovate and drive progress within the industry.


[Address]:
Main office address is in NOVO ALLE DK 2880 None BAGSVAERD DENMARK,G7 00000
tel: 4544448888


[Stock]:
